Verapamil Hydrochloride NDC 52536-880

NDC codes

FDA NDC Directory

Product NDC (as listed)52536-880Labeler and product segments. Claims need a package NDC.

Product NDC at billing width52536-0880Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
52536-880-01	52536088001	100 CAPSULE, DELAYED RELEASE in 1 BOTTLE, PLASTIC (52536-880-01)Marketed from Nov 26, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Verapamil Hydrochloride
Generic name (nonproprietary): verapamil hydrochloride
Active ingredients: Verapamil hydrochloride — 120 mg/1
Dosage form: Capsule, Delayed release
Route: Oral
Labeler: Wilshire Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 019614
Marketing start: May 29, 1990
Listing expires: Dec 31, 2026
Other FDA classes: Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)
Identifiers: Product ID 52536-880_27eb9340-eaec-754a-e063-6394a90a4f6eSPL ID 27eb9340-eaec-754a-e063-6394a90a4f6eSPL set ID f9399858-fd7a-4b73-8759-3e5bf3af2666UNII V3888OEY5RUPC 0352536886017, 0352536882019
Pharmacologic class: Calcium Channel Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N452536088001 followed by a unit qualifier and the quantity

Package 52536-0880-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 27, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Verapamil hydrochloride sustained-release capsules are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 019614

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 019614
Product	Strength	Form · route	Labeler	Product NDC
Verapamil Hydrochloride	Verapamil hydrochloride 180 mg/1	Capsule, Delayed releaseOral	Wilshire Pharmaceuticals, Inc.	52536-882
Verapamil Hydrochloride	Verapamil hydrochloride 240 mg/1	Capsule, Delayed releaseOral	Wilshire Pharmaceuticals, Inc.	52536-884
Verapamil Hydrochloride	Verapamil hydrochloride 360 mg/1	Capsule, Delayed releaseOral	Wilshire Pharmaceuticals, Inc.	52536-886
Verapamil Hydrochloride	Verapamil hydrochloride 120 mg/1	Capsule, Delayed release pelletsOral	Teva Pharmaceuticals Inc	0591-2880